Panduratin A, a Possible Inhibitor in Metastasized A549 Cells through Inhibition of NF-Kappa B Translocation and Chemoinvasion
Open Access
- 24 July 2013
- Vol. 18 (8) , 8764-8778
Abstract
In the present study, we investigated the effects of panduratin A (PA), isolated from Boesenbergia rotunda, on apoptosis and chemoinvasion in A549 human non-small cell lung cancer cells. Activation of the executioner procaspase-3 by PA was found to be dose-dependent. Caspase-3 activity was significantly elevated at the 5 µg/mL level of PA treatment and progressed to a maximal level. However, no significant elevated level was detected on procaspase-8. These findings suggest that PA activated caspase-3 but not caspase-8. Numerous nuclei of PA treated A549 cells stained brightly by anti-cleaved PARP antibody through High Content Screening. This result further confirmed that PA induced apoptotic cell death was mediated through activation of caspase-3 and eventually led to PARP cleavage. Treatment of A549 cells with PA resulted in a strong inhibition of NF-κB activation, which was consistent with a decrease in nuclear levels of NF-κB/p65 and NF-κB/p50 and the elevation of p53 and p21. Besides that, we also showed that PA significantly inhibited the invasion of A549 cells in a dose-dependent manner through reducing the secretion of MMP-2 of A549 cells gelatin zymography assay. Our findings not only provide the effects of PA, but may also be important in the design of therapeutic protocols that involve targeting of either p53 or NF-κB.Keywords
This publication has 43 references indexed in Scilit:
- MDM2, MDMX and p53 in oncogenesis and cancer therapyNature Reviews Cancer, 2013
- In Vitro and In Vivo Anti-Angiogenic Activities of Panduratin APLOS ONE, 2012
- Panduratin A Inhibits the Growth of A549 Cells through Induction of Apoptosis and Inhibition of NF-KappaB TranslocationMolecules, 2011
- Role of NF-kB, p53, and p21 in the Regulation of TNF-α Mediated Apoptosis of LymphocytesBulletin of Experimental Biology and Medicine, 2010
- p21 in cancer: intricate networks and multiple activitiesNature Reviews Cancer, 2009
- CDK Inhibitors: Cell Cycle Regulators and BeyondDevelopmental Cell, 2008
- Matrix metalloproteinases as modulators of inflammationSeminars in Cell & Developmental Biology, 2008
- A role for endothelial-derived matrix metalloproteinase-2 in breast cancer cell transmigration across the endothelial-basement membrane barrierClinical & Experimental Metastasis, 2007
- Matrix metalloproteinases and the regulation of tissue remodellingNature Reviews Molecular Cell Biology, 2007
- Flavonoids: Promising anticancer agentsMedicinal Research Reviews, 2003